Sort   by:  
 Page size 
UnknownHigh-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
Not available
S-EPMC4979201 | biostudies-literature
UnknownThe effect of North Carolina free clinics on hospitalizations for ambulatory care sensitive conditions among the uninsured.
Not available
S-EPMC5897934 | biostudies-literature
UnknownPhase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.
Not available
S-EPMC5455685 | biostudies-literature
UnknownRandomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.
Not available
S-EPMC6018511 | biostudies-literature
TranscriptomicsBMP-7 microarray in human articular cartilage
Responses of human adult articular chondrocytes under conditions of lack or excess of bone morphogenetic protein-7 also called osteogenic protein 1. Original processed data file is in E-MTAB-571.additional.zip archive.
ORGANISM(S): Homo sapiens 
2011-03-09 | E-MTAB-571 | biostudies-arrayexpress
TranscriptomicsGene expression data from MCF-7 cells treated with Lacciac Acid A
Lacciac Acid A was indentified as an inhibitor of DMNT1. MCF-7 cells were treated with Lacciac Acid A (200 uM) for 5 days. Changes in gene expression were identified by using Affymetrix Human gene ST1.0 arrays. We used microarrays to determine global changes in gene expression upon treatment with La...
ORGANISM(S): Homo sapiens 
2013-09-03 | E-GEOD-45804 | biostudies-arrayexpress
UnknownPrognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Not available
S-EPMC4162494 | biostudies-literature
GenomicsInstitut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Neuroblastoma, a clinically heterogeneous pediatric cancer, is characterized by distinct genomic profiles but few recurrent mutations. As neuroblastoma is expected to have high degree of genetic heterogeneity, study of neuroblastoma's clonal evolution with deep coverage whole-genome sequencing of di...
EGAS00001001184 | EGA
GenomicsNeuroblastoma relapse trio series from the AMC
The majority of neuroblastoma patients have tumors that initially respond to chemotherapy, but a large proportion of patients will experience therapy-resistant relapses. The molecular basis of this aggressive phenotype is unknown. Whole genome sequencing of 23 paired diagnostic and relapsed neurobla...
EGAS00001001183 | EGA
GenomicsInstitut Curie Neuroblastoma data access Committee
Data Access Committee EGAC00001000319
EGAC00001000319 | EGA
Sort   by:  
 Page size